Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.09 AUD | -2.48% | +4.26% | +15.28% |
26/02 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
25/02 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.28% | 391M | |
+20.32% | 43.95B | |
+20.53% | 22.49B | |
+11.68% | 14.71B | |
+11.31% | 13.77B | |
+42.32% | 12.3B | |
-9.10% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Purchasing Global Rights to Topical Treatment RHOFADE